Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Jin Qi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Advanced Healthcare Materials|October 23, 2024
A Multiple Targeting Genome Editing System for Remodulation of Circulating Malignant Cells to Eliminate Cancer Immunosuppression and Restore Immune ResponsesXiao-He Ren, Tao Guo, Ma-Fei Xu, et al.
ACS Applied Bio Materials|May 12, 2025
Dual-Targeting Protein-Based Delivery System for Enhanced Drug Therapy of Neurodegenerative DisordersJia-Lin Wang, Yi-Ying Dong, Pei-Ling Liu, et al.
International Journal of Biological Macromolecules|June 27, 2026
Targeting delivery systems with aptamer-conjugated hyaluronic acid for personalized assessment of treatment response to targeted cancer therapyQing-Yu Gao, Di Han, Xin-Ru Liao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 14, 2025
Aptamer-functionalized nanoparticles for CRISPR-Cas9 delivery to circulating malignant cells for therapeutic efficacy evaluationXin-Ru Liao, Di Han, Li-Jin Qi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 20, 2026
Advanced Delivery Systems for Non-perturbative Monitoring Patient-Specific Cancer-Immune Dynamics for Precision Personalized TherapyXin-Ru Liao, Di Han, Li-Jin Qi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Advanced Healthcare Materials|October 23, 2024
A Multiple Targeting Genome Editing System for Remodulation of Circulating Malignant Cells to Eliminate Cancer Immunosuppression and Restore Immune ResponsesXiao-He Ren, Tao Guo, Ma-Fei Xu, et al.
ACS Applied Bio Materials|May 12, 2025
Dual-Targeting Protein-Based Delivery System for Enhanced Drug Therapy of Neurodegenerative DisordersJia-Lin Wang, Yi-Ying Dong, Pei-Ling Liu, et al.
International Journal of Biological Macromolecules|June 27, 2026
Targeting delivery systems with aptamer-conjugated hyaluronic acid for personalized assessment of treatment response to targeted cancer therapyQing-Yu Gao, Di Han, Xin-Ru Liao, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 14, 2025
Aptamer-functionalized nanoparticles for CRISPR-Cas9 delivery to circulating malignant cells for therapeutic efficacy evaluationXin-Ru Liao, Di Han, Li-Jin Qi, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 20, 2026
Advanced Delivery Systems for Non-perturbative Monitoring Patient-Specific Cancer-Immune Dynamics for Precision Personalized TherapyXin-Ru Liao, Di Han, Li-Jin Qi, et al.
Pageof 1